Home > Financial Ratios > AKUMS DRUGS & PHARMACEUTICALS

AKUMS DRUGS & PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
AKUMS DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 229.02-59.12655.88-122.1254.92

What is the latest Core EBITDA Growth ratio of AKUMS DRUGS & PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of AKUMS DRUGS & PHARMACEUTICALS is 229.02 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025229.02
Mar2024-59.12
Mar2023655.88
Mar2022-122.12
Mar202154.92

How is Core EBITDA Growth of AKUMS DRUGS & PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 229.02
Positive
Mar2024 -59.12
Negative
Mar2023 655.88
Positive
Mar2022 -122.12
Negative
Mar2021 54.92 -

Other Financial Ratios of AKUMS DRUGS & PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of AKUMS DRUGS & PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AKUMS DRUGS & PHARMACEUTICALS ₹8,254.8 Cr 7.4% 4.7% 14.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,370.0 Cr -3.9% -8.9% -3.2% Stock Analytics
DIVIS LABORATORIES ₹161,193.0 Cr 3.8% -4.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,438.0 Cr 3.2% -5.6% 26.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,097.0 Cr 3.3% -6% 11% Stock Analytics
CIPLA ₹97,846.7 Cr 0.8% -9.1% -13.1% Stock Analytics


AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AKUMS DRUGS & PHARMACEUTICALS

7.4%

4.7%

14.9%

SENSEX

3.7%

-0.9%

0.7%


You may also like the below Video Courses